What is Ginkgo Bioworks's equity method investments?

Ginkgo Bioworks (DNA) reported equity method investments of $13.31M in Q1 2026.

What is the long-term trend for Ginkgo Bioworks's equity method investments?

Over 3 years (2020 to 2023), Ginkgo Bioworks's equity method investments has grown at a -100.0% compound annual growth rate (CAGR), from $28.92M to $0.

What does equity method investments mean?

Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.

Ginkgo Bioworks DNA Equity Method Investments

Equity Method Investments at other companies

Charles River LaboratoriesCRL

$209.72M-2.0%

AbCellera Biologics Inc.ABCL

$32.5M+0.6%

Bio-Rad LaboratoriesBIO

$23.7M+3.0%

Agilent TechnologiesA

$54M-11.5%

Other financials

Income statement

See full

Revenue$19.5M-49.1%

Gross profit$16.4M-52.0%

Operating income-$71.4M+11.9%

Net income-$82.6M+9.2%

EPS (diluted)-$1.42+27.6%

Balance sheet

See full

Cash & equivalents$188.7M-46.9%

Total debt$410.7M-5.5%

Total equity$443.2M-31.6%

Total assets$1.0B-20.1%

Cash flow

See full

Operating cash flow-$46.7M+9.4%

CapEx$1.9M-74.6%

Free cash flow-$48.6M+17.8%

Valuation

See full

Market cap$625.16M+24.6%

Enterprise value$847.19M+45.9%

P/S4.4×+2.2×

Profitability

See full

Operating margin-210.7%+7.6pp

Net margin-215.4%+8.3pp

FCF margin-119%-21.2pp

Returns & leverage

See full

Return on equity-55.8%-1.8pp

Debt / equity0.9×+0.3×

Current ratio5.2×+0.3×

Where this comes from

Reported directly by Ginkgo Bioworks in its filing.

Tagged under the XBRL concept us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount.

The official record: Ginkgo Bioworks’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ginkgo Bioworks's equity method investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ginkgo Bioworks's equity method investments?: Ginkgo Bioworks (DNA) reported equity method investments of $13.31M in Q1 2026.
What is the long-term trend for Ginkgo Bioworks's equity method investments?: Over 3 years (2020 to 2023), Ginkgo Bioworks's equity method investments has grown at a -100.0% compound annual growth rate (CAGR), from $28.92M to $0.
What does equity method investments mean?: Investments in unconsolidated affiliates and joint ventures where the company has significant influence (typically 20-50% ownership), carried at proportional book value.